Publication | Closed Access

Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism

Cannabis UseFirst-pass MetabolismIntestinal Lymphatic TransportPost-prandial Oral BioavailabilityFunctional SelectivityMedicineImmunologyGastroenterologyPharmacologyCannabinoid PharmacologyGastrointestinal Peptide Hormone